These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 6158582

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Chemokine CXCL12 and its receptor CXCR4 expression are associated with perineural invasion of prostate cancer.
    Zhang S, Qi L, Li M, Zhang D, Xu S, Wang N, Sun B.
    J Exp Clin Cancer Res; 2008 Nov 04; 27(1):62. PubMed ID: 18983683
    [Abstract] [Full Text] [Related]

  • 28. Characterization of corpora amylacea glycoconjugates in normal and hyperplastic glands of human prostate.
    Morales E, Polo LA, Pastor LM, Santamaría L, Calvo A, Zuasti A, Ferrer C.
    J Mol Histol; 2005 May 04; 36(4):235-42. PubMed ID: 16200455
    [Abstract] [Full Text] [Related]

  • 29. Kinetic parameters of 5 alpha-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates.
    Bruchovsky N, Rennie PS, Batzold FH, Goldenberg SL, Fletcher T, McLoughlin MG.
    J Clin Endocrinol Metab; 1988 Oct 04; 67(4):806-16. PubMed ID: 2458378
    [Abstract] [Full Text] [Related]

  • 30. Phosphotyrosine antibodies preferentially react with basal epithelial cells in the dog prostate.
    Landry F, Chapdelaine A, Bégin LR, Chevalier S.
    J Urol; 1996 Jan 04; 155(1):386-90. PubMed ID: 7490893
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Pathologic characteristics of pseudohyperplastic prostatic adenocarcinoma].
    Zhang HZ, Jiang ZM, Shi L.
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov 04; 36(11):742-5. PubMed ID: 18307877
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The expression of neuropeptides in hyperplastic and malignant prostate tissue and its possible clinical implications.
    Yu DS, Hsieh DS, Chen HI, Chang SY.
    J Urol; 2001 Sep 04; 166(3):871-5. PubMed ID: 11490236
    [Abstract] [Full Text] [Related]

  • 36. [Problems of so-called atypical hyperplasia of the prostate].
    Mehlhorn J.
    Z Urol Nephrol; 1987 Jul 04; 80(7):379-85. PubMed ID: 2444040
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Microautoradiographic quantitation of vascular endothelial growth factor mRNA levels in human prostate specimens containing normal and neoplastic epithelium.
    Woessner RD, Wright PS, Loudy DE, Wallace CD, Montgomery LR, Nestok BR.
    Exp Mol Pathol; 1998 Jul 04; 65(1):37-52. PubMed ID: 9613925
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Reduction of the weight of prostatic tissue during transurethral resection].
    Alkhouja AS, Gazaigne J.
    Prog Urol; 1997 Feb 04; 7(1):48-50. PubMed ID: 9116738
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.